Linda Friedman

Current treatments often fall short because getting protective therapies directly to an injured, compromised brain during the critical recovery window is incredibly difficult. Our team of researchers developed a unique, dual-treatment approach combining a localized implant at the injury site with peripheral supplementation. Our Breakthrough Ratio: Our newly developed, patent-pending ratio of 300:1:10 (CBD to THC to supplementary compounds) achieved the highest levels of recovery in learning, memory, and motor tasks, while actively reducing anxiety. Moving Beyond the Lab: We have peer-reviewed data, published sequels, and patent-pending status to protect this discovery. Now, as a formalized partnership, NeuroInfusions LLC is ready to bridge the gap between lab-bench breakthroughs and real-world medical solutions. Translating biotechnology is a rigorous and costly endeavor. Your donations will go directly toward funding our immediate corporate milestones: Advanced Dual-Treatment Testing, Pre-Clinical Development, Lab Resources & Regulatory Compliance, launching early clinical trials to demonstrate safety, efficacy, and targeted neurological recovery, and moving toward a standardized, high-quality product designed for real-world use. By supporting our campaign, you aren't just funding research but rather you are backing a protected, peer-reviewed breakthrough that could fundamentally rewrite the prognosis for brain trauma survivors everywhere. Thank you for standing with NeuroInfusions LLC, sharing our mission, and believing in the power of precision medicine.